Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Partnership to develop gene editing therapies for neurological, muscular diseases
Regeneron Pharmaceuticals Inc. and Intellia Therapeutics Inc. have announced an expanded research collaboration intended to develop additional CRISPR-based gene editing therapies focused on neurological and muscular diseases.
Use of AI software led to improved outcomes for those with intracranial hemorrhage
Use of artificial intelligence triage software led to a significant reduction in 30- and 120-day all-cause mortality for those with intracranial hemorrhage compared with those treated without the algorithm, according to research.
Log in or Sign up for Free to view tailored content for your specialty!
FDA removes partial clinical hold on IND for rare pediatric disease drug-device combo
A Bay Area biotech company announced the FDA has lifted the partial clinical hold on EryDel SpA’s investigational new drug application for EryDex to treat ataxia-telangiectasia, a rare pediatric neurological disorder.
Continuous subcutaneous foslevodopa/foscarbidopa improved PD symptoms at 1 year
Continuous subcutaneous infusion of foslevodopa/foscarbidopa improved “on” time and reduced “off” time in those with Parkinson’s disease at 52 weeks, with a favorable safety and tolerability profile, per research from Neurology and Therapy.
Speaker offers advice on how to achieve goals through inspiration, not end result
Goal setting should be centered around purpose, action plans and motivation rather than the achievement alone, a presenter at the Women in Medicine Summit explained.
Electrical stimulation to the tongue can help treat gait deficit symptoms in MS
As a neuro clinical specialist in physical therapy, I treat many people with multiple sclerosis.
Q&A: Online health care prices often 'wildly different' from estimates offered over phone
Price transparency is considered a step in the right direction when it comes to taming health care costs, but researchers have found that prices for certain hospital services can differ — often wildly — from what is presented.
FDA accepts IND with partial clinical hold for oral small molecule Alzheimer’s treatment
The FDA has accepted an investigational new drug application for VG-3927, an oral small molecule TREM2 agonist for the potential treatment of Alzheimer’s disease, according to the manufacturer.
Four tools that provide both asset protection and tax benefits
As an orthopedic surgeon and an attorney/wealth manager who has worked with more than 1,000 physicians, we know that asset protection and tax planning are two of the highest interest planning areas for physicians.
Electrical stimulation may reduce OSA severity in patients with low CPAP adherence
In patients with obstructive sleep apnea and poor CPAP adherence, domiciliary transcutaneous electrical stimulation for 3 months improved disease severity compared with CPAP, according to results published in eClinicalMedicine.
-
Headline News
Screen use in bed associated with delayed sleep, psychological distress in children, teens
September 25, 20243 min read -
Headline News
Q&A: Barriers to STI self-testing among teens, young adults
September 25, 20243 min read -
Headline News
Inadequate sleep during pregnancy tied to neurodevelopmental delays for boys
September 26, 20243 min read
-
Headline News
Screen use in bed associated with delayed sleep, psychological distress in children, teens
September 25, 20243 min read -
Headline News
Q&A: Barriers to STI self-testing among teens, young adults
September 25, 20243 min read -
Headline News
Inadequate sleep during pregnancy tied to neurodevelopmental delays for boys
September 26, 20243 min read